Connect Biopharma Holdings Limited
Organization details
- Legal name
- Connect Biopharma Holdings Limited
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- China
- Fiscal year end
- December
- Ticker symbol
- CNTB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001835268
Board of directors
-
Barry D. Quart · Director · Chief Executive OfficerSince 2026
-
James A. Schoeneck · DirectorSince 2026
-
James Huang · DirectorSince 2026
-
Jean I. Liu · DirectorSince 2026
-
Karen J. Wilson · DirectorSince 2026
-
Kleanthis Gabriel Xanthopoulos · DirectorSince 2026
Chief executives
Board connections
5 of this board's directors also sit on 9 other boards. 9 are in the same sector.
-
Alaunos Therapeutics Inc. Same sectorvia James Huang
-
Atara Biotherapeutics Inc. Same sectorvia James Huang
-
Calidi Biotherapeutics Inc. Same sectorvia James A. Schoeneck
-
Elicio Therapeutics Inc. Same sectorvia Karen J. Wilson
-
Erasca Inc. Same sectorvia Jean I. Liu
-
Heron Therapeutics Inc. Same sectorvia Barry D. Quart
-
Kiniksa Pharmaceuticals International plc Same sectorvia Barry D. Quart
-
Kyntra Bio Inc. Same sectorvia James A. Schoeneck
-
Serina Therapeutics Inc. Same sectorvia Karen J. Wilson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $4,374,000
- 2 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Jean I. Liu Director | Grant or award | +8,984 | — | — |
| Sep 30, 2026 | Kleanthis Gabriel Xanthopoulos Director | Grant or award | +5,000 | — | — |
| Jun 30, 2026 | Jean I. Liu Director | Grant or award | +6,718 | — | — |
| Jun 30, 2026 | Kleanthis Gabriel Xanthopoulos Director | Grant or award | +3,738 | — | — |
| May 29, 2026 | James Huang Director | Open-market purchase | +150,000 | $2.48 | $372,000 |
| Mar 31, 2026 | Kleanthis Gabriel Xanthopoulos Director | Grant or award | +2,816 | — | — |
| Mar 31, 2026 | Jean I. Liu Director | Grant or award | +5,061 | — | — |
| Mar 31, 2026 | James Huang Director | Open-market purchase | +1,160,000 | $3.45 | $4,002,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Connect Biopharma Holdings Limited
Who is the CEO of Connect Biopharma Holdings Limited?
Barry D. Quart has been Connect Biopharma Holdings Limited's Chief Executive Officer since March 2026.
How many directors are on Connect Biopharma Holdings Limited's board?
Connect Biopharma Holdings Limited's board has 6 directors: Barry D. Quart, James A. Schoeneck, James Huang, Jean I. Liu, Karen J. Wilson and Kleanthis Gabriel Xanthopoulos.
Are Connect Biopharma Holdings Limited insiders buying or selling shares?
Over the last 12 months, Connect Biopharma Holdings Limited insiders bought $4.4 million of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="connect-biopharma-holdings-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.